Thad Allen Huston - 10 Mar 2026 Form 4 Insider Report for Artiva Biotherapeutics, Inc. (ARTV)

Role
Chief Financial Officer
Signature
/s/ Andrew Cronauer, Attorney-in-Fact
Issuer symbol
ARTV
Transactions as of
10 Mar 2026
Net transactions value
$0
Form type
4
Filing time
10 Mar 2026, 16:47:06 UTC
Previous filing
24 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Huston Thad Allen Chief Financial Officer C/O ARTIVA BIOTHERAPEUTICS, INC., 5505 MOREHOUSE DRIVE, SUITE 100, SAN DIEGO /s/ Andrew Cronauer, Attorney-in-Fact 10 Mar 2026 0001706052

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARTV Common Stock Award +220,000 $0.000000* 220,000 10 Mar 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock unit award granted under the Issuer's 2025 Inducement Plan.